A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent renal malignant cancer, whose survival rate and quality of life of patients are still not satisfactory. Nevertheless, the TNM staging system currently used in clinical cannot make accurate survival predictions and precise treatment...

Full description

Bibliographic Details
Main Authors: Jiyue Wu MM, Feilong Zhang MM, Jiandong Zhang MD, Zejia Sun MM, Changzhen Hao MM, Huawei Cao MM, Wei Wang MD
Format: Article
Language:English
Published: SAGE Publishing 2021-06-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211027923
_version_ 1819043937736720384
author Jiyue Wu MM
Feilong Zhang MM
Jiandong Zhang MD
Zejia Sun MM
Changzhen Hao MM
Huawei Cao MM
Wei Wang MD
author_facet Jiyue Wu MM
Feilong Zhang MM
Jiandong Zhang MD
Zejia Sun MM
Changzhen Hao MM
Huawei Cao MM
Wei Wang MD
author_sort Jiyue Wu MM
collection DOAJ
description Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent renal malignant cancer, whose survival rate and quality of life of patients are still not satisfactory. Nevertheless, the TNM staging system currently used in clinical cannot make accurate survival predictions and precise treatment decisions for ccRCC patients. Therefore, there is an urgent need for more reliable biomarkers to identify high-risk subgroups of ccRCC patients to guide timely intervention and treatment. Recently, MiRNAs have been shown to be closely related to the procession of a variety of tumors, and they have high stability in various tissues, which makes them suggested to have the potential as a prognostic biomarker of ccRCC. In this study, by analyzing and processing the miRNAs expression profile of ccRCC patients from the TCGA database, we finally constructed an excellent miRNAs signature and verified it through a variety of methods. In order to build a more accurate and reliable clinical predictive model, we integrated the miRNAs signature with other prognostic-related clinical parameters to construct a nomogram. Functional enrichment analysis showed that miRNAs in the signature may regulate the genes involved in the Hippo signaling pathway, Tight junction, and Wnt signaling pathway to cause different prognoses of ccRCC patients, which may provide a reference for subsequent basic research and targeted therapy. To conclude, our study constructed a useful miRNAs signature, which allows the prognosis stratification for ccRCC patients and thereby guides the timely and effective interventions on high-risk patients. At the same time, this study also found the potential biological pathways involved in the procession of ccRCC.
first_indexed 2024-12-21T10:04:43Z
format Article
id doaj.art-5e4d7ba3fd324743af4867e8fa2025bf
institution Directory Open Access Journal
issn 1533-0338
language English
last_indexed 2024-12-21T10:04:43Z
publishDate 2021-06-01
publisher SAGE Publishing
record_format Article
series Technology in Cancer Research & Treatment
spelling doaj.art-5e4d7ba3fd324743af4867e8fa2025bf2022-12-21T19:07:51ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382021-06-012010.1177/15330338211027923A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell CarcinomaJiyue Wu MM0Feilong Zhang MM1Jiandong Zhang MD2Zejia Sun MM3Changzhen Hao MM4Huawei Cao MM5Wei Wang MD6 Institute of Urology, Capital Medical University, Beijing, China Institute of Urology, Capital Medical University, Beijing, China Institute of Urology, Capital Medical University, Beijing, China Institute of Urology, Capital Medical University, Beijing, China Institute of Urology, Capital Medical University, Beijing, China Institute of Urology, Capital Medical University, Beijing, China Institute of Urology, Capital Medical University, Beijing, ChinaClear cell renal cell carcinoma (ccRCC) is one of the most prevalent renal malignant cancer, whose survival rate and quality of life of patients are still not satisfactory. Nevertheless, the TNM staging system currently used in clinical cannot make accurate survival predictions and precise treatment decisions for ccRCC patients. Therefore, there is an urgent need for more reliable biomarkers to identify high-risk subgroups of ccRCC patients to guide timely intervention and treatment. Recently, MiRNAs have been shown to be closely related to the procession of a variety of tumors, and they have high stability in various tissues, which makes them suggested to have the potential as a prognostic biomarker of ccRCC. In this study, by analyzing and processing the miRNAs expression profile of ccRCC patients from the TCGA database, we finally constructed an excellent miRNAs signature and verified it through a variety of methods. In order to build a more accurate and reliable clinical predictive model, we integrated the miRNAs signature with other prognostic-related clinical parameters to construct a nomogram. Functional enrichment analysis showed that miRNAs in the signature may regulate the genes involved in the Hippo signaling pathway, Tight junction, and Wnt signaling pathway to cause different prognoses of ccRCC patients, which may provide a reference for subsequent basic research and targeted therapy. To conclude, our study constructed a useful miRNAs signature, which allows the prognosis stratification for ccRCC patients and thereby guides the timely and effective interventions on high-risk patients. At the same time, this study also found the potential biological pathways involved in the procession of ccRCC.https://doi.org/10.1177/15330338211027923
spellingShingle Jiyue Wu MM
Feilong Zhang MM
Jiandong Zhang MD
Zejia Sun MM
Changzhen Hao MM
Huawei Cao MM
Wei Wang MD
A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma
Technology in Cancer Research & Treatment
title A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma
title_full A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma
title_fullStr A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma
title_full_unstemmed A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma
title_short A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma
title_sort novel mirna based model can predict the prognosis of clear cell renal cell carcinoma
url https://doi.org/10.1177/15330338211027923
work_keys_str_mv AT jiyuewumm anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT feilongzhangmm anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT jiandongzhangmd anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT zejiasunmm anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT changzhenhaomm anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT huaweicaomm anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT weiwangmd anovelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT jiyuewumm novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT feilongzhangmm novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT jiandongzhangmd novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT zejiasunmm novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT changzhenhaomm novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT huaweicaomm novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma
AT weiwangmd novelmirnabasedmodelcanpredicttheprognosisofclearcellrenalcellcarcinoma